📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Achievements and obstacles of remyelinating therapies in multiple sclerosis. (2017)

First Author: Stangel M

Attributed to: Capital award for UK DRI at Imperial College London funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nrneurol.2017.139

PubMed Identifier: 29146953

Publication URI: http://europepmc.org/abstract/MED/29146953

Type: Journal Article/Review

Volume: 13

Parent Publication: Nature reviews. Neurology

Issue: 12

ISSN: 1759-4758